Company intelligence / Profile preview

MTN

Fayetteville, Arkansas, United Statesmtn.com ↗

Ownership: Public · MTN
Development stage: Commercial

Overview

Boston Mountain Biotech developed patented technologies to improve the efficiency of recombinant protein production and purification. Their innovations aimed to help large pharmaceutical companies streamline manufacturing processes. The company was awarded grants such as from the National Science Foundation for their work but has since closed operations.

Modalities: ProteinRecombinant protein
Industry: Non-Drug Biotech

Financials

Market cap: $4.8B
Total revenue: $1.2B
Enterprise value: $7.6B

Beyond the preview

Go deeper on MTN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTN.

Explore the full profile